MedTrace Logo

A Study to Evaluate the Efficacy and Safety of a Leave-in Spray in Subjects With Head Lice Infestation

NCT05565820 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2025-02-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of Vamousse Spray 'n' Go, compared to a 1% Permethrin control shampoo, in the treatment of head lice.

Conditions

  • Pediculosis Capitis
  • Lice Infestations
  • Head Lice

Interventions

OTHER

Vamousse Spray 'n' Go

Pediculicide for topical application, active ingredient Natrum Muriaticum 2X (HPUS).

DRUG

Nix Creme Rinse Lice Treatment

1% permethrin lotion for topical application.

Sponsors & Collaborators

  • South Florida Family Health and Research Centers

    collaborator NETWORK

  • Alliance Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Susel L Gonzalez Acosta, APRN · South Florida Family Health and Research Centers

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2023-03-12
Completion
2023-03-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05565820 on ClinicalTrials.gov